Chair's Address to Shareholders
Filed with ASX · · 3 pages · English
Bio-Gene Technology Ltd. on 6ix
In the deck
Story so far
Earlier from Bio-Gene Technology
- Qcide receives organic listing status in USA
- Response to ASX Aware Letter
- Positive Flavocide Efficacy Results Presented
- Appendix 4E and 2025 Annual Report
- Result of Security Purchase Plan
Later from Bio-Gene Technology
- CEO's Presentation
- Bio-Gene Receives $519,500 R&D Tax Incentive
- U.S. Department of Defense Grant Programs Advance
- Quarterly Activities/Appendix 4C Cash Flow Report
- Appendix 4D and Half-Year Accounts 31 December 2025
Follow Bio-Gene Technology into a list and get an email when it puts out news.
Follow Bio-Gene Technology